menu search

U.s. fda approves expanded use of biomarin's dwarfism therapy

The U.S. Food and Drug Administration (FDA) on Friday approved the expanded use of BioMarin pharmaceutical...

October 20, 2023, 4:15 pm

: lipella pharmaceuticals stock more than doubles in 3 days as fda approves ind for olp treatment

Shares of Lipella pharmaceuticals Inc. LIPO rocketed 52.2% higher in very active tracing Friday, after ...

October 20, 2023, 2:47 pm

Adial pharmaceuticals announces $4 million private placement priced at-the-market under nasdaq rules

CHARLOTTESVILLE, Va., Oct. 20, 2023 (GLOBE NEWSWIRE) — Adial pharmaceuticals, Inc. (NASDAQ:ADIL) (“...

October 20, 2023, 12:00 pm

Biocryst to host r&d day on november 3

RESEARCH TRIANGLE PARK, N.C., Oct. 20, 2023 (GLOBE NEWSWIRE) — BioCryst pharmaceuticals, Inc. (Nasdaq...

October 20, 2023, 11:00 am

Lipella pharmaceuticals stock more than doubles in 3 days as fda approves ind for olp treatment

Shares of Lipella pharmaceuticals Inc. LIPO, +51.55% rocketed 52.2% higher in very active tracing Frida...

October 20, 2023, 10:47 am

What's in store for west pharmaceutical (wst) in q3 earnings?

West pharmaceutical's (WST) third-quarter 2023 results are likely to reflect strength in the Proprietar...

October 20, 2023, 9:01 am

Why is xortx therapeutics (xrtx) stock up 110% today?

Xortx Therapeutics (NASDAQ: XRTX ) stock is climbing higher on Friday despite a lack of news from the pharmac...

October 20, 2023, 8:42 am

Arcutis announces pricing of $100 million public offering

WESTLAKE VILLAGE, Calif., Oct. 19, 2023 (GLOBE NEWSWIRE) — Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT) (“Arcutis”), an early commercial-stage b...

October 20, 2023, 3:45 am

Biomarin: growth drivers remain intact

During Q2 2023, BioMarin pharmaceutical's revenues for the quarter has reached $595.3 million, a 12% Yo...

October 19, 2023, 11:04 pm

Terns pharmaceuticals to participate in upcoming investor conferences

FOSTER CITY, Calif., Oct. 19, 2023 (GLOBE NEWSWIRE) — Terns pharmaceuticals, Inc. (“Terns” or the...

October 19, 2023, 8:05 pm

Shareholder alert: pomerantz law firm investigates claims on behalf of investors of alnylam pharmaceuticals, inc. – alny

NEW YORK, Oct. 19, 2023 (GLOBE NEWSWIRE) — Pomerantz LLP is investigating claims on behalf of investors of Alnylam ...

October 19, 2023, 7:33 pm

Shareholder alert: levi & korsinsky, llp notifies investors of an investigation involving possible securities fraud violations by officers of alnylam pharmaceuticals, inc.(alny)

NEW YORK, Oct. 19, 2023 (GLOBE NEWSWIRE) — Levi & Korsinsky notifies investors that it has commenced an investigation of Alnylam ...

October 19, 2023, 5:13 pm

Webinar invitation: transform pharma with ai driven insights

BLOOMINGTON, Ind., Oct. 19, 2023 (GLOBE NEWSWIRE) — Medical teams of life sciences and pharmaceutical...

October 19, 2023, 4:46 pm

Gild or vrtx: which is the better value stock right now?

Investors interested in Medical - Biomedical and Genetics stocks are likely familiar with Gilead Sciences (GILD) and Vertex ...

October 19, 2023, 12:47 pm

Adial pharmaceuticals to present at the fall foliage microcap rodeo conference on october 25th

CHARLOTTESVILLE, VA / ACCESSWIRE / October 19, 2023 / Adial pharmaceuticals, Inc. (NASDAQ:ADIL) ("Adial...

October 19, 2023, 12:00 pm

Pfizer wins unconditional eu antitrust okay for $43 bln seagen buy

U.S. pharmaceutical company Pfizer gained unconditional EU antitrust approval on Thursday for its propo...

October 19, 2023, 10:54 am

Is invesco pharmaceuticals etf (pjp) a strong etf right now?

A smart beta exchange traded fund, the Invesco pharmaceuticals ETF (PJP) debuted on 06/23/2005, and off...

October 19, 2023, 7:31 am

In need of a turnaround: will walgreens' new ceo cut or spare its high-yield dividend?

A healthcare and pharmaceutical benefits manager veteran is coming in to lead the turnaround....

October 19, 2023, 6:02 am

Verona pharma to report third quarter 2023 financial results and provide corporate update

LONDON and RALEIGH, N.C., Oct. 19, 2023 (GLOBE NEWSWIRE) -- Verona Pharma plc (Nasdaq: VRNA) (“Verona Pharma” or the “Company”), a clinical-st...

October 19, 2023, 2:00 am

Ultragenyx announces pricing of public offering of common stock and pre-funded warrants

NOVATO, Calif., Oct. 18, 2023 (GLOBE NEWSWIRE) — Ultragenyx pharmaceutical Inc. (NASDAQ: RARE), a bio...

October 19, 2023, 1:16 am


Search within

Pages Search Results: